4th Edition of International Precision Medicine Conference

August 17-19, 2023 | Online Event

August 17-19, 2023 | Online Event

2023 Speakers

Sergey Suchkov, Speaker at Personalized Medicine Conference
Keynote Presentation
Sergey Suchkov, Institute for Biotech & Global Health of RosBioTech and A.I. Evdokimov MGMSU, Russian Federation

A new and upgraded approach to the diseased states and wellness, and to re-shape tomorrow’s healthcare whilst doing it today, resulted in a new global trend in the healthcare services, namely, Personalized and Precision Medicine (PPM). PPM as a Unique Entity demonstrating a [....] » Read More

Matthias Schwab, Speaker at Precision Medicine Congress
Keynote Presentation
Matthias Schwab, University of Tubingen, Germany

The goal of personalized medicine is to provide individualized treatment and to predict the clinical outcome of different treatments in different patients. Pharmacogenomics (PGx) is one of the core elements in personalized medicine. The basic concept is that interindividual varia [....] » Read More

Bernd Blobel, Speaker at Precision Medicine Congress
Keynote Presentation
Bernd Blobel, University of Regensburg, Germany

For meeting the financial, quality and safety challenges as well as expectations of the patients, health and social care systems around the globe currently undergo a transformation towards personalized, preventive, predictive, participative precision medicine (5PM), supported by [....] » Read More

Ahmed Raza Khan, Speaker at Precision Medicine Congress
Oral Presentation
Ahmed Raza Khan, Australian National University, Australia

Folding is an effective technique to alter the optoelectronic properties of two-dimensional (2D) materials such as interlayer coupling, bandgap, etc. Optical techniques such as PL, Raman were used in the past to probe the folds localization. Here, we show that optical second harm [....] » Read More

 Kavitha Palaniappan, Speaker at Precision Medicine Conferences
Oral Presentation
Kavitha Palaniappan, Duke-NUS Medical School, Singapore

Background: Genetic testing can be categorised into clinical and non-clinical genetic testing. A clinical genetic testing involves predictive screening or testing for a disease as well as purposes that purport to assess, diagnose, prevent, alleviate or treat a medical condition [....] » Read More

Pei Ting Sarah Chou, Speaker at Precision Medicine Congress
Oral Presentation
Pei Ting Sarah Chou, Regulatory Affairs Professionals Society, Taiwan

First, the existing regulatory frameworks for in vitro diagnostic and artificial intelligence medicinal products will be examined. Among those medicinal products of in vitro diagnostic and artificial intelligence, the ones characterized as precision medicine, or personalized medi [....] » Read More

Nurul Syakima Ab Mutalib, Speaker at Precision Medicine Congress
Oral Presentation
Nurul Syakima Ab Mutalib, Universiti Kebangsaan Malaysia, Malaysia

Colorectal cancer (CRC) metastasis remains a significant challenge, and the presence of cancer stem cells (CSCs) within circulating tumor cells (CTCs) plays a critical role in this process. This study aimed to unravel the cancer stem cell signatures in CTCs of metastatic colorect [....] » Read More

Francis Tieng Yew Fu, Speaker at Precision Medicine Congress
Oral Presentation
Francis Tieng Yew Fu, Universiti Kebangsaan Malaysia, Malaysia

Molecular single-cell analyses have revolutionised the current understanding of complex biological processes by revealing rare cell populations, including circulating tumour cells (CTCs), that were previously masked by bulk analyses. While CTCs have proven to be valuable prognost [....] » Read More

Yuji Yokouchi, Speaker at Precision Medicine Congress
Oral Presentation
Yuji Yokouchi, Kumamoto University, Japan

Precision medicine refers to personalized medicine that provides medical care tailored to the individual based on his or her individual constitution. One of the promising tools is genome editing with CRISPR-Cas system, which enables modification of specific genes in an individual [....] » Read More

Fuhong He, Speaker at Precision Medicine Congress
Oral Presentation
Fuhong He, Beijing Institute of Genomics, China

Cancer patients can achieve dramatic responses to chemotherapy yet retain resistant tumor cells, which ultimately results in relapse. Although xenograft model studies have identified several cellular and molecular features that are associated with chemoresistance in acute myeloid [....] » Read More

Guo Wei He, Speaker at Precision Medicine Congress
Oral Presentation
Guo Wei He, Tianjin University, China

Background: Tetralogy of Fallot (TOF) is a common congenital heart malformation. Genetic variants in the CITED2 coding region is known to be significantly associated with cardiac malformation, but the role of variants in the CITED2 promoter region in the development of TOF remain [....] » Read More

Isabella Friis Jorgensen , Speaker at Precision Medicine Conferences
Oral Presentation
Isabella Friis Jorgensen , University of Copenhagen, Denmark

Unfortunately, diagnostic errors are common, and the increasing co-occurrence of diseases also increases the risk of erroneous diagnoses. We present a data-driven, generic approach for identifying patients potentially at risk of being mis- or over-diagnosed, here exemplified by C [....] » Read More

Stefania Di Mauro, Speaker at Personalized Medicine Conferences
Oral Presentation
Stefania Di Mauro, University of Catania, Italy

Background: Type 2 diabetes and renal damage are strictly linked. The progressive increase in T2D incidence has stimulated the interest in novel biomarkers to improve the diagnostic performance of commonly utilized markers such as albuminuria and eGFR. Methods: Through [....] » Read More

Boris Tankhilevich, Speaker at Personalized Medicine Conferences
Oral Presentation
Boris Tankhilevich, Magtera, Inc., United States

(I) Alzheimer's Disease Facts and Figures, an annual report released by the Alzheimer's Association, reveals the burden of Alzheimer's and dementia on individuals, caregivers, government and the nation's health care system. Per the special report, More Than Normal [....] » Read More

Thomas Webster, Speaker at Precision Medicine Congress
Oral Presentation
Thomas Webster, Interstellar Therapeutics, United States

Artificial intelligence has already changed the world. Here, this invited talk, will provide a review of how artificial intelligence (AI) can be used in medicine. By learning from how patients respond to certain therapies, AI can be used to predict clinical outcomes for that spec [....] » Read More

David W Hein, Speaker at Precision Medicine Congress
Oral Presentation
David W Hein, University of Louisville, United States

Recent investigations more clearly define the effects of N-acetyltransferase 2 (NAT2) haplotypes and genotypes on the expression of acetylator phenotype towards selected drugs within human hepatocytes in vitro, within human hepatocyte cultures in situ, and clinical measures such [....] » Read More

Wei Wu, Speaker at Precision Medicine Congress
Oral Presentation
Wei Wu, UCSF, United States

Molecularly targeted cancer therapy has improved outcomes for patients with cancer with targetable oncoproteins, such as mutant EGFR in lung cancer. Yet, the long-term survival of these patients remains limited, because treatment responses are typically incomplete. One potential [....] » Read More

Mehrbod Vakhshoori, Speaker at Precision Medicine Congress
Oral Presentation
Mehrbod Vakhshoori, Loma Linda University, United States

Background: Inflammation is believed to play a role in the pathogenesis of heart failure (HF). However, the potential role of platelet-to-lymphocyte ratio (PLR) as a novel biomarker for assessing HF prognosis requires further investigation. The aim of this study was to evaluate t [....] » Read More

Qianqian Song, Speaker at Precision Medicine Congress
Oral Presentation
Qianqian Song, Wake Forest University School of Medicine, United States

Cell–cell communications are vital for biological signaling and play important roles in complex diseases. Recent advances in single cell spatial transcriptomics (SCST) technologies allow examining the spatial cell communication landscapes and hold the promise for disentangl [....] » Read More

Arun Rishi, Speaker at Precision Medicine Congress
Oral Presentation
Arun Rishi, Wayne State University, United States

NF-κB is a pro-inflammatory transcription factor that regulates pathways for DNA Damage repair, cell survival and apoptosis, and contributes to emergence of resistance to genotoxic chemotherapy in a variety of cancers. Cell cycle and apoptosis regulatory protein 1 (CARP-1 o [....] » Read More

Ekaterina Minskaia, Speaker at Precision Medicine Congress
Oral Presentation
Ekaterina Minskaia, Sirius University of Science and Technology, Russian Federation

Oncolytic viruses (OV) are a relatively novel class of anti-tumor therapies. Their selective replication in tumor cells and activation of the host immune response lead to the death of only malignant cells setting OV-based therapies apart from the non-specific conventional chemo-/ [....] » Read More

Lina Carvalho, Speaker at Precision Medicine Congress
Poster Presentation
Lina Carvalho, Faculty of Medicine of the University of Coimbra, Portugal

ALK rearrangements are detected in 2–5% of NSCLCs (85% correspond to EML4-ALK) sensitive to ALK TKIs; resistance mutations schedule is unknown. A case demonstrates NGS as the actual methodology for recognition of rearrangements, amplifications, and point mutations. Metho [....] » Read More

Deborah Shelton, Speaker at Precision Medicine Congress
Keynote Presentation
Deborah Shelton, Appendix Cancer PMP (ACPMP) Research Foundation, United States

Appendiceal cancer is a rare cancer for which there is critical unmet medical need. Although it is a rare cancer, findings from a 2020 study reflect that the overall incidence of malignant appendiceal tumors has significantly increased in the U.S. and Canada from 2000 to 2016. &n [....] » Read More

Juan He, Speaker at Precision Medicine Congress
Oral Presentation
Juan He, Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine, China

Background: Colonization of carbapenem-resistant Enterobacterale (CRE) is considered as one of vital preconditions for infection, with corresponding high morbidity and mortality. It is indispensable to construct a reliable prediction model and develop preventive and therapeutic s [....] » Read More

Will be updated soon......
Watsapp